ArticleThe Iowa orthopaedic journal2025
Prevalence, Risk Factors, and Clinical Impact of Bony Cysts in the Dysplastic Hip Undergoing Periacetabular Osteotomy: An Exploratory Study.
Article in The Iowa orthopaedic journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Formation of bone cysts in the acetabulum or femoral head is common in symptomatic acetabular dysplasia, but the prevalence and significance of cysts in hips undergoing PAO is poorly understood. The purposes of this study were (1) to determine the prevalence of cysts in hips undergoing PAO, (2) to identify predictors of the presence of cysts, (3) to determine if the presence or location of cysts was associated with intra-articular damage and (4) to determine if the presence or location of cysts impacted early clinical outcomes after PAO. Methods: We performed a retrospective review of 270 consecutive hips (249 patients) who were diagnosed with symptomatic acetabular dysplasia and underwent PAO without previous ipsilateral hip surgery. Preoperative low-dose CTs were utilized to identify the presence of cysts, and patient-reported outcome measures (PROs) were recorded at baseline and 1-year minimum follow-up (223 hips, 83%). The prevalence of cysts was reported, and associated factors were determined by univariate analysis (Student's T-test/Mann-Whitney U test for continuous measures, Chi-squared test/ Fischer's exact test for dichotomous measures). PROs and clinical "composite failure", defined as reoperation or failure to reach both the MCID and PASS, were similarly compared. Results: CT analysis of 270 dysplastic hips undergoing PAO demonstrated 17.0% (n=46) with acetabular (13.7%) or femoral cysts (4.4%). Hips with cysts were older (31.0±9.2 years) than those without cysts (24.1±7.9 years, p<0.001), reported higher Tonnis OA grade (p<0.001), showed higher rates of femoral chondromalacia (p=0.008), and had greater acetabular inclination (16.9° ±6.1) compared to hips without cysts (14.8° ±5.9, p=0.046). At 1-year minimum follow-up (223 hips, 83%), neither the presence nor location of cysts significantly impacted PROs. Cystic hips showed an increased but statistically insignificant difference in reoperations, conversion to THA, or composite failure outcomes. Conclusion: Seventeen percent of dysplastic hips undergoing PAO had acetabular (13.7%) or femoral (4.4%) cysts on CT. Cysts in dysplastic hips were associated with increased Tonnis grade and acetabular inclination but did not significantly impact early PROs. Greater composite failure rates failed to show statistical significance, suggesting that patients with cystic dysplasia should continue counseling for hip-preserving treatments.
Indexed as
Identifiers
40606719PMC12212318What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.